Mike Youle
Publications by Year
Research Areas
HIV/AIDS Research and Interventions, HIV/AIDS drug development and treatment, HIV Research and Treatment, HIV-related health complications and treatments, Pneumocystis jirovecii pneumonia detection and treatment
Most-Cited Works
- → Efficacy of short-term monotherapy with maraviroc, a new CCR5 antagonist, in patients infected with HIV-1(2005)491 cited
- → Emergence of CXCR4-Using Human Immunodeficiency Virus Type 1 (HIV-1) Variants in a Minority of HIV-1-Infected Patients following Treatment with the CCR5 Antagonist Maraviroc Is from a Pretreatment CXCR4-Using Virus Reservoir(2006)331 cited
- → Rapid decline in detectability of HIV-1 drug resistance mutations after stopping therapy(1999)285 cited
- → British HIV Association guidelines for the treatment of HIV‐1‐positive adults with antiretroviral therapy 2012(2012)217 cited
- → Late presenters in the era of highly active antiretroviral therapy(2004)215 cited
- → British HIV Association guidelines for the treatment of HIV‐1‐positive adults with antiretroviral therapy 2012 (Updated November 2013. All changed text is cast in yellow highlight.)(2013)194 cited
- → Randomized Trial to Evaluate Indinavir/Ritonavir versus Saquinavir/Ritonavir in Human Immunodeficiency Virus Type 1–Infected Patients: The MaxCmin1 Trial(2003)118 cited
- → Sexual dysfunction associated with protease inhibitor containing highly active antiretroviral treatment(2001)117 cited
- → Acetyl-l-carnitine(2004)94 cited
- → Changes Over Time in Risk of Initial Virological Failure of Combination Antiretroviral Therapy(2006)91 cited